Wellinks

Wellinks provides virtual pulmonary rehabilitation and personalized chronic obstructive pulmonary disease (COPD) management through its Spire RPM System, which combines wearable sensor technology with predictive patient care. Following its acquisition of Spire Health, the company delivers continuous respiratory data monitoring that enables earlier intervention and personalized care plans. The platform demonstrates 45% fewer COPD-related ER visits, 65% reduction in hospitalization, and $11,300 average annual savings per patient. The comprehensive program includes virtual pulmonary rehabilitation, one-on-one clinical coaching from certified health coaches and respiratory therapists, at-home monitoring with wearable sensors, 24/7 nurse triage, and educational resources. The company partners with health plans, health systems, primary care practices, and Medicare Advantage plans, identifying eligible patients and providing seamless enrollment with appointments available within two days. Less than 4% of eligible COPD patients currently have access to pulmonary rehabilitation, which Wellinks addresses through its value-based care model. Founded in 2013 and headquartered in New Haven, United States, the company has raised approximately $28.5M in Series A funding from investors including Connecticut Innovations, HighCape Capital, and Morningside.

Wearable Technology > Health and Wellness Devices > Respiratory,

Disease Self Management > Respiratory Diseases > Therapy > Device

College Wise > Yale University